Buprenorphine
| Material: | 1 ml serum |
| Indication | Therapeutic drug monitoring, also testing for drug abuse, compliance and abstinence checks |
| Therapeutic range | 1 – 10 µg/l |
| Please note | The metabolite norbuprenorphine is automatically determined as part of buprenorphine evaluation. Buprenorphine is a strong painkiller of the opioid analgesics group, which is also used as a substitution in heroin withdrawal therapy. Its effect on the opiate receptor is 25 – 40 times higher than that of morphine. The antidote is naloxone, same as for other opiates and opioids. The side effect spectrum is typical (vomiting, constipation, nausea, vertigo, tiredness, hypotension, respiratory depression amongst others). |
| Accredited | ja |
More Results for the letter B
- Babesiosis (BABE)
- Babesia
- Bacillus anthracis (BACIL A)
- Anthrax
- Balantidium coli (BALAN CO)
- Intestinal parasites
- Barbiturates (BARB)
- Bartonella henselae (KKKH)
- previously Rochalimaea henselae
- Bartonella quintana (KKKQ)
- previously Rochalimaea quintana
- BCR-ABL fusion gene (PHIL)
- Philadelphia translocation/ t9 / 22
- Bence-Jones proteins in the urine (BENCE)
- Benperidol (BENP)
- Benzene/Benzol (BENZOL)
- Benzodiazepines, Benzodiazepine differentiation (BENZ)
- Beryllium (BERYL)
- Be
- Bile acids in the serum (GALL)
- Bile acids in the stool (GALLS)
- Bile duct epithelium autoantibodies (GALEP)
- Bilharziasis (SCHIS)
- Schistosomiasis
- Biliary canaliculi, autoantibodies to (BILI02)
- Biliary epithelial cells of the small bile ducts, autoantibodies to (BILI03)
- Biliary pigments (BILI01)
- Bilirubin in the serum, direct (BILD)
- conjugated
- Bilirubin in the serum, indirect (BIIN)
- non-conjugated bilirubin
- Bilirubin in the serum, total (BILI)
- Biotin (VITH)
- Vitamin H
- Biotinidase (BIOTIN)
- Bivaracetam (BIVA)
- Blastocystis hominis (BLASTO)
- intestinal parasites
- Blastomycosis (BLAS)
- Blastomyces dermatitidis
- Bleeding time (Bleet)
- Blood count (KBB)
- Blood culture (BLUTKUL)